By: Blanco  S.B. No. 2212
         (In the Senate - Filed March 9, 2023; March 22, 2023, read
  first time and referred to Committee on Health & Human Services;
  April 25, 2023, reported adversely, with favorable Committee
  Substitute by the following vote:  Yeas 6, Nays 0; April 25, 2023,
  sent to printer.)
Click here to see the committee vote
 
  COMMITTEE SUBSTITUTE FOR S.B. No. 2212 By:  Kolkhorst
 
 
A BILL TO BE ENTITLED
 
AN ACT
 
  relating to the disclosure by a pharmacy to a patient of certain
  price information for a drug or biological product.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 562.003, Occupations Code, is amended to
  read as follows:
         Sec. 562.003.  DISCLOSURE OF PRICE; PATIENT'S OPTION.  (a)  A
  pharmacy shall disclose the lowest cost cash price at that pharmacy
  for the drug or biological product prescribed to the patient.
         (b)  If the price of a drug or biological product to a patient
  is lower than the amount of the patient's copayment under the
  patient's prescription drug insurance plan, the pharmacist shall
  offer the patient the option of paying for the drug or biological
  product at the lower price instead of paying the amount of the
  copayment.
         SECTION 2.  This Act takes effect September 1, 2023.
 
  * * * * *